Partial protection of oncogene, anti-sense oligodeoxynucleotides against serum nuclease degradation using terminal methylphosphonate groups.

[1]  L. J. Maher,et al.  Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylphosphonates in a cell-free system. , 1988, Nucleic acids research.

[2]  A. Harel-Bellan,et al.  Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytes. , 1988, Journal of immunology.

[3]  A. Nienhuis,et al.  An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation , 1988, Molecular and cellular biology.

[4]  E. Wickstrom,et al.  Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Eric Wickstrom,et al.  A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1 , 1987, Nature.

[6]  E. Ohtsuka,et al.  Site-directed cleavage of RNA. , 1987, Nucleic acids research.

[7]  B. Franza,et al.  Expression of normal and mutant ras proteins in human acute leukemia. , 1987, Oncogene.

[8]  S. Agrawal,et al.  Oligodeoxynucleoside methylphosphonates: synthesis and enzymic degradation , 1987 .

[9]  P. Zamecnik,et al.  Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[10]  L. Aurelian,et al.  Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Wickstrom.  Oligodeoxynucleotide stability in subcellular extracts and culture media. , 1986, Journal of biochemical and biophysical methods.

[12]  A. Murakami,et al.  Characterization of sequence-specific oligodeoxyribonucleoside methylphosphonates and their interaction with rabbit globin mRNA. , 1985, Biochemistry.

[13]  M. Caruthers,et al.  Synthesis of oligodeoxynucleotides and oligodeoxynucleotide analogs using phosphoramidite intermediates , 1984 .

[14]  A. Murakami,et al.  Preparation of oligodeoxyribonucleoside methylphosphonates on a polystyrene support. , 1983, Nucleic acids research.

[15]  I. Gibson,et al.  Effects of bis(6-mercaptopurine-9-beta-D-ribofuranoside)-5',5"-phosphate and its butyryl derivative on mouse leukaemia L1210 and a 6-mercaptopurine-resistant subline in culture. , 1982, Biochemical pharmacology.

[16]  K. Jayaraman,et al.  Biochemical and biological effects of nonionic nucleic acid methylphosphonates. , 1981, Biochemistry.

[17]  P. Miller,et al.  Oligothymidylate analogues having stereoregular, alternating methylphosphonate/phosphodiester backbones. Synthesis and physical studies. , 1980, The Journal of biological chemistry.

[18]  Helen Donis-Keller,et al.  Site specific enzymatic cleavage of RNA , 1979, Nucleic Acids Res..

[19]  M. Stephenson,et al.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. , 1978, Proceedings of the National Academy of Sciences of the United States of America.